VANCOUVER, British Columbia, December 16, 2011 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Novellus Systems (NASDAQ:NVLS), athenahealth (NASDAQ:ATHN), InterMune (NASDAQ:ITMN), JPMorgan (NYSE:JPM), Lam Research (NASDAQ:LRCX) and Oracle (NASDAQ:ORCL).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Report Highlights:
Novellus Systems, Inc. (NASDAQ:NVLS): Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of Novellus Systems, Inc. (NASDAQ: NVLS) concerning possible breaches of fiduciary duty and other violations of law related to the Company's entry into an agreement to be acquired by Lam Research Corp. in an all-stock transaction with an approximate value of US$3.3 billion. On Dec 15, Novellus Systems stock price reached US$40.37 for 16.34% up, 31.92 million stock shares traded which was 20 times as average volume. Want to trace the activities of company insiders from now on? Check out the insider trading here. Read Full Report: http://www.insiderslab.com/PR3/121611A/NVLS/NovellusSystems.pdf
athenahealth, Inc (NASDAQ:ATHN): On Dec 15, athenahealth, Inc. (NASDAQ: ATHN), a leading provider of cloud-based practice management, electronic health record (EHR), and care coordination services to medical groups, announced that it has received the top ranking for its cloud-based EHR, athenaClinicals®, in the annual 2011 Best in KLAS Awards: Software & Services report for ambulatory EMR (11-75 Physicians). Insiderslab.com found company Senior Vice President, Chief Marketing Officer, Robert L. Cosinuke, sold 3,000 shares at stock price US$60.33 on Dec 12. Do you want to know when company insiders will buy their shares? It can be done for free by registering below. Read Full Report http://www.insiderslab.com/PR3/121611A/ATHN/athenahealth.pdf
InterMune, Inc. (NASDAQ:ITMN): By the end of Thursday's trading, InterMune, Inc. fell US$5.55 (-30.34%) to US$12.74 on heavy volume. Throughout the day, 19.74 million shares of InterMune, Inc. exchanged hands as compared to its average daily volume of 1.12 million shares. InterMune, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies in pulmonology and fibrotic diseases. Are insiders start taking huge profits by selling shares or exercising stock options? Add ITMN into your watch list for insider trade now. Read Full Report http://www.insiderslab.com/PR3/121611A/ITMN/InterMune.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
JPMorgan Chase & Co. (NYSE:JPM):
Read Full Report: http://www.insiderslab.com/PR3/121611A/JPM/JPMorgan.pdf
Lam Research Corporation (NASDAQ:LRCX):
Read Full Report: http://www.insiderslab.com/PR3/121611A/LRCX/LamResearch.pdf
Oracle Corporation (NASDAQ:ORCL):
Read Full Report: http://www.insiderslab.com/PR3/121611A/ORCL/Oracle.pdf
More Individual Stock Reports & Sector Reports:
http://www.insiderslab.com/media/
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Insiderslab.com:
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit http://www.insiderslab.com/disclaimers/disclaimers.php for details.
